InMed Pharmaceuticals Inc. Reports Earnings Results for the Second Quarter and Six Months Ended December 31, 2023
February 13, 2024 at 05:06 pm EST
InMed Pharmaceuticals Inc. reported earnings results for the second quarter and six months ended December 31, 2023. For the second quarter, the company reported sales was USD 1.24 million compared to USD 0.469783 million a year ago. Net loss was USD 1.48 million compared to USD 2.1 million a year ago. Basic loss per share from continuing operations was USD 0.19 compared to USD 0.91 a year ago. Diluted loss per share from continuing operations was USD 0.19 compared to USD 0.91 a year ago.
For the six months, sales was USD 2.14 million compared to USD 0.790571 million a year ago. Net loss was USD 4.02 million compared to USD 5.61 million a year ago. Basic loss per share from continuing operations was USD 0.71 compared to USD 3.54 a year ago. Diluted loss per share from continuing operations was USD 0.71 compared to USD 3.54 a year ago.